ARCHIVES

DCT Advisors Approve Recompetition Of Drug Discovery Groups

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

Annual Report Finds Cancer Incidence And Death Rates Fell For First Time.

December 5, 2008

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Cancer Letter Skips Next Two Weeks

September 2, 1988